Thanks to advances in breast cancer treatment, more women are living longer after their diagnosis than ever before. But as survival rates improve, researchers are paying closer attention to what happens after treatment ends. For many survivors, the effects of chemotherapy do not disappear when the last infusion is completed. A recent study examined older breast...
Muscle weakness is one of the biggest challenges of aging. As people get older, they naturally lose muscle strength and muscle mass, a condition known as sarcopenia. This can make everyday activities like climbing stairs, carrying groceries, or getting up from a chair much more difficult. While exercise and good nutrition remain the best ways to slow muscle loss, researchers are searching for new treatments that target the underlying causes of age-related muscle weakness.
Many people take glucosamine supplements every day to help support their joints. It has been used for years and is one of the most popular supplements for osteoarthritis. However, a new study is raising questions about whether glucosamine could affect brain health in people with Alzheimer’s disease or mild cognitive impairment.
Tampons are absorbent products that you insert into your vagina to soak up menstrual flow during your period. Tampons come in different absorbency levels — like light, regular, and super — so you can pick the right one for your flow. Some have a plastic or cardboard applicator to help with insertion, and others are inserted with your finger.
Xylitol was linked to a higher risk of heart attack, stroke, or cardiovascular death.
Paracetamol, also called acetaminophen, taken during pregnancy was linked to smaller ovaries and fewer egg-containing follicles in daughters.
And a review study found that for esophageal cancer, adding surgery after chemoradiation was linked to better survival than chemoradiation alone.
Fayuvi is a one-time, intravenous (given directly into a vein) gene therapy that uses a modified, non-infectious virus called an adeno-associated virus serotype 9 (AAV9) to deliver a working copy of the SGSH gene into the patient’s cells. This enables the body’s cells to produce sulfamidase — the enzyme that is missing or deficient in MPS IIIA — allowing heparan sulfate to be properly broken down in lysosomes and reducing its harmful buildup throughout the body and brain.